Trial Profile
A Pilot Trial of Adjunctive Prednisone and Mycobacterium w Immunotherapy in Tuberculous Pericarditis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Oct 2018
Price :
$35
*
At a glance
- Drugs Cadi 05 (Primary) ; Prednisolone; Prednisone
- Indications Pericarditis; Tuberculosis
- Focus Therapeutic Use
- Acronyms IMPI
- 02 Sep 2014 Status changed from active, no longer recruiting to completed, as per ClinicalTrials.gov record.
- 08 Apr 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 03 Jan 2012 Planned number of patients changed from 800 to 1400 as reported by ClinicalTrials.gov.